Enlargements of somatosensory-evoked potentials in progressive supranuclear palsy

Acta Neurologica Scandinavica

Volumn 106, Issue 4, 2002, Pages 209-212

  Miwa, Hideto ^a   Mizuno, Y ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Parkinsonism; Progressive supranuclear palsy; Somatosensory evoked potential

Indexed keywords

ADULT; AGED; AMPLITUDE MODULATION; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ELECTRONEUROLOGY; ESSENTIAL TREMOR; EVOKED SOMATOSENSORY RESPONSE; HUMAN; MAJOR CLINICAL STUDY; MEDIAN NERVE; MUSCLE ACTION POTENTIAL; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PROGRESSIVE SUPRANUCLEAR PALSY;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; ESSENTIAL TREMOR; EVOKED POTENTIALS, SOMATOSENSORY; HUMANS; MEDIAN NERVE; MIDDLE AGED; PARKINSON DISEASE; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 0036785012     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2002.01223.x     Document Type: Article

References (22)

1. STEEL JC, RICHARDSON IC, OLZEWSKI J. Progressive supranuclear palsy. A heteregenous degeneration involving the brain stem, basal ganglia and cerebellum, with vertical gaze and pseudobulbar palsy, nuclear dystonia and dementia. Arch Neurol 1964;10:333-59.
2. LITVAN I, AGID Y, CALNE D et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
3. GIMENEZ-ROLDAN S, MATEO D, BENITO C, GRANDAS F, PEREZ-GILABERT Y. Progressive supranuclear palsy and corticobasal ganglionic degeneration: differentiation by clinical features and neuroimaging techniques. J Neural Transm Suppl 1994;42:79-90.
4. YAMAUCHI H, FUKUYAMA H, NAGAHAMA Y et al. Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy. Ann Neurol 1997;41:606-14.
5. ROSSINI PM, BABILONI F, BERNARDI G et al. Abnormalities of short-latency somatosensory evoked potentials in parkinsonian patients. Electroencephalogr Clin Neurophysiol 1989;74:277-89.
6. ROSSINI PM, TRAVERSA R, BOCCASENA P et al. Parkinson's disease and somatosensory evoked potentials: apomorphine-induced transient potentiation of frontal components. Neurology 1993;43:2495-500.
7. ONOFRJ M, GHILARDI MF, BASCIANI M, MARTINEZ-TICA J, GLOVER A. Attenuation of the early anterior negativity of median nerve somatosensory evoked potential in the MPTP-treated monkey. Neurophysiol Clin 1990;20:283-93.
8. GARCIA PA, AMINOFF MJ, GOODIN DS. The frontal N30 component of the median-derived SEP in patients with predominantly unilateral Parkinson's disease. Neurology 1995;45:989-92.
9. KOFLER M, MULLER J, REGGIANI L, WENNING GK. Somatosensory evoked potentials in progressive supranuclear palsy. J Neurol Sci 2000;179:85-91.
10. HOEHN MM, YAHR MD. Parkinsonism: onset, prognosis and mortality. Neurology 1967;17:427-42.
11. FINDLEY LJ, KOLLER WC. Definitions and behavioral classifications. In: FINDLEY LJ, KOLLER WC eds. Handbook of tremor disorders. New York: Marcel Dekker, 1995;1-5.
12. SHIBASAKI H, YAMASHITA Y, NESHIGE R, TOBIMATSU S, FUKUI R. Pathogenesis of giant somatosensory evoked potentials in progressive myoclonic epilepsy. Brain 1985;108:225-40.
13. SHIBASAKI H, IKEDA A, NAGAMINE T et al. Cortical reflex negative myoclonus. Brain 1994;117:477-86.
14. MIWA H, MORI H, ABE K, HOSHINO I, MIZUNO Y. Corticobasal degeneration and progressive supranuclear palsy - differentiation by somatosensory-evoked potentials. No To Shinkei Geka 1996;48:253-7.
15. DESMEDT JE, CHERON G. Somatosensory evoked potentials to finger stimulation in healthy octogenarians and in young adults: wave forms, scalp topography and transit times of parietal and frontal components. Electroencephalogr Clin Neurophysiol 1980;50:404-25.
16. BHATIA KP, BROWN P, GREGORY R et al. Progressive myoclonic ataxia associated with coeliac disease. The myoclonus is of cortical origin, but the pathology is in the cerebellum. Brain 1995;118:1087-93.
17. TIJSSEN MA, THOM M, ELLISON DW et al. Cortical myoclonus and cerebellar pathology. Neurology 2000;54:1350-6.
18. JELLINGER K, RIEDERER P, TOMONAGA M. Progressive supranuclear palsy: clinico-pathological and biochemical studies. J Neural Transm (Suppl) 1980;16:111-28.
19. ARAI N. 'Grumose degeneration' of the dentate nucleus. A light and electron microscopic study in progressive supranuclear palsy and dentatorubropallidoluysial atrophy. J Neurol Sci 1989;90:131-45.
20. CRUZ-SANCHEZ FF, ROSSI ML, CARDOZO A, PICARDO A, TOLOSA E. Immunohistological study of grumose degeneration of the dentate nucleus in progressive supranuclear palsy. J Neurol Sci 1992;110:228-31.
21. MIZUSAWA H, YEN SH, HIRANO A, LLENA JF. Pathology of the dentate nucleus in progressive supranuclear palsy: a histological, immunohistochemical and ultrastructural study. Acta Neuropathol (Berl) 1989;78:419-28.
22. MATSUMOTO R, NAKANO I, ARAI N, ODA M, YAGISHITA S, HASHIZUME Y. Loss of the dentate nucleus neurons is associated with torpedo formation: amorphometric study in progressive supranuclear palsy and dentatorubropallidoluysian atrophy. Acta Neuropathol (Berl) 1998;95:149-53.